ADA2 and Pure red cell aplasia: Our results provide further proof of concept for the efficacy of gene transfer strategies for the treatment of DADA2 using LV and the EFS promoter, which rescued stem cells and their progeny from a patient with ADA2-associated red cell aplasia.